Sign in to continue:

Saturday, February 21st, 2026
us corporate news

Artiva Biotherapeutics, Inc. 8-K Filing: Company Information, Address, and SEC Details (2026)

Posted on February 20, 2026 at 5:38 pm (GMT+8)

14
Views
Share on Facebook
Share on Twitter

NIL
Disclaimer:
This article is for informational purposes only and does not constitute investment advice. Readers are encouraged to conduct their own research and consult with their financial advisor before making any investment decisions.

View Artiva Biotherapeutics, Inc. Historical chart here



Related Posts

us corporate news

Valaris Reports Strong Q4 2025 Results, $900M Backlog Increase, and Announces Transocean Merger
minichart
February 20, 2026

Valaris Q4 2025 Earnings: Key Investor Takeaways Valaris Limited Reports Q4 2025 Results: Strong Operational Performance, \$900M Backlog Added, and Pending Transocean Merger Key Points for Investors Exceptional Revenue Efficiency: Achieved 98% revenue efficiency...

us corporate news

Service Corporation International (SCI) Declares Q1 2026 Cash Dividend and Provides Forward-Looking Statement
minichart
February 20, 2026

Service Corporation International Declares Quarterly Cash Dividend Key Highlights Quarterly Cash Dividend Announced: Service Corporation International (SCI), North America’s largest provider of deathcare products and services, has declared a quarterly cash dividend of \$0.34...

us corporate news

Strawberry Fields REIT Reports Record 2025 Operating Results with Strong FFO Growth, Major Acquisitions, and Expanded Healthcare Portfolio
minichart
February 20, 2026

Strawberry Fields REIT Announces Outstanding 2025 Year-End Results and Strategic Expansion Strawberry Fields REIT Reports Record 2025 Results, Aggressive Expansion, and Strong FFO Growth South Bend, IN – February 19, 2026: Strawberry Fields REIT,...

   Ad